Related references
Note: Only part of the references are listed.Layered double hydroxides and LDH-derived materials in chosen environmental applications: a review
Dylan Chaillot et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2021)
Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysis
Yuan Zhou et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Albumin-stabilized layered double hydroxide nanoparticles synergized combination chemotherapy for colorectal cancer treatment
Li Li et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2021)
Repurposing of Pirfenidone (Anti-Pulmonary Fibrosis Drug) for Treatment of Rheumatoid Arthritis
Donghao Gan et al.
FRONTIERS IN PHARMACOLOGY (2021)
Germacrone improves liver fibrosis by regulating the PI3K/AKT/mTOR signalling pathway
De Ji et al.
CELL BIOLOGY INTERNATIONAL (2021)
TGF-β1-induced EMT activation via both Smad-dependent and MAPK signaling pathways in Cu-induced pulmonary fibrosis
Hongrui Guo et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2021)
Optimally designed theranostic system based folic acids and chitosan as a promising mucoadhesive delivery system for encapsulating curcumin LbL nano-template against invasiveness of breast cancer
Nemany A. N. Hanafy
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
TIM-4 interference in Kupffer cells against CCL4-induced liver fibrosis by mediating Akt1/Mitophagy signalling pathway
Hao Wu et al.
CELL PROLIFERATION (2020)
Collagen biology and non-invasive biomarkers of liver fibrosis
Morten A. Karsdal et al.
LIVER INTERNATIONAL (2020)
Encapsulation of curcumin into layered double hydroxides improve their anticancer and antiparasitic activity
Filiberto Gutierrez-Gutierrez et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2020)
Mucoadhesive curcumin crosslinked carboxy methyl cellulose might increase inhibitory efficiency for liver cancer treatment
Nemany A. N. Hanafy et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2020)
Berberine attenuates severity of chronic pancreatitis and fibrosis via AMPK-mediated inhibition of TGF-β1/Smad signaling and M2 polarization
Sapana Bansod et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
Fibroblast growth factor 2 conjugated superparamagnetic iron oxide nanoparticles (FGF2-SPIONs) ameliorate hepatic stellate cells activation in vitro and acute liver injury in vivo
Dhadhang Wahyu Kurniawan et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells
Zhemin Shi et al.
CELL DEATH & DISEASE (2020)
Piperlongumine attenuates bile duct ligation-induced liver fibrosis in mice via inhibition of TGF-β1/Smad and EMT pathways
Shrilekha Chilvery et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells
Valentina Masola et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
MicroRNA-101 suppresses liver fibrosis by downregulating PI3K/Akt/mTOR signaling pathway
Yang Lei et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2019)
Mucoadhesive Hydrogel Nanoparticles as Smart Biomedical Drug Delivery System
Nemany A. N. Hanafy et al.
APPLIED SCIENCES-BASEL (2019)
Salvianolic acid A attenuates CCl4-induced liver fibrosis by regulating the PI3K/AKT/mTOR, Bcl-2/Bax and caspase-3/cleaved caspase-3 signaling pathways
Rong Wang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019
Bedair Dewidar et al.
CELLS (2019)
Layered Double Hydroxides Are Promising Nanomaterials for Tissue Bioengineering Application
Celio Jr da Costa Fernandes et al.
ADVANCED BIOSYSTEMS (2019)
New insights into TGF-β/Smad signaling in tissue fibrosis
He-He Hu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer
Takuma Tsuchida et al.
JOURNAL OF HEPATOLOGY (2018)
Sorafenib-loaded polymeric micelles as passive targeting therapeutic agents for hepatocellular carcinoma therapy
Yanhong Su et al.
NANOMEDICINE (2018)
Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-B Pathway
Qiang Ou et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-beta/Smad signaling pathway
Mao Mu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Activated hepatic stellate cells promote epithelial-to-mesenchymal transition in hepatocellular carcinoma through transglutaminase 2-induced pseudohypoxia
Hui Ma et al.
COMMUNICATIONS BIOLOGY (2018)
Nanoparticles for the treatment of liver fibrosis
Suchithra Poilil Surendran et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Sorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT Study
Tom M. Ganten et al.
CLINICAL CANCER RESEARCH (2017)
Sorafenib: A potential therapeutic drug for hepatic fibrosis and its outcomes
Rui Ma et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy
Dae Won Kim et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2017)
pH sensitive nano layered double hydroxides reduce the hematotoxicity and enhance the anticancer efficacy of etoposide on non-small cell lung cancer
Rongrong Zhu et al.
ACTA BIOMATERIALIA (2016)
Epithelial-mesenchymal transition in tissue repair and fibrosis
Rivka C. Stone et al.
CELL AND TISSUE RESEARCH (2016)
The PI3K AKT pathway in the pathogenesis of prostate cancer
Xiaofei Wen
Frontiers in Bioscience-Landmark (2016)
Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis
Shu Dong et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2016)
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets
Chong-Yang Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Epithelial-mesenchymal transition in liver fibrosis
Ya-Lei Zhao et al.
BIOMEDICAL REPORTS (2016)
MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway
Weiping Dai et al.
LIVER INTERNATIONAL (2015)
Repression of Smad7 mediated by DNMT1 determines hepatic stellate cell activation and liver fibrosis in rats
Er-Bao Bian et al.
TOXICOLOGY LETTERS (2014)
New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis
Yan Wang et al.
JOURNAL OF HEPATOLOGY (2010)
Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies
Stefanie Hemmann et al.
JOURNAL OF HEPATOLOGY (2007)
Smads 2 and 3 are differentially activated by transforming growth factor-β (TGF-β) in quiescent and activated hepatic stellate cells -: Constitutive nuclear localization of Smads in activated cells is TGF-β-independent
CH Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The role of Smad3 in mediating mouse hepatic stellate cell activation
B Schnabl et al.
HEPATOLOGY (2001)
Share Paper
